Hsbc Holdings PLC Increases Stock Position in Corteva, Inc. $CTVA

Hsbc Holdings PLC boosted its holdings in Corteva, Inc. (NYSE:CTVA) by 16.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,479,864 shares of the company’s stock after purchasing an additional 211,386 shares during the quarter. Hsbc Holdings PLC’s holdings in Corteva were worth $125,360,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of CTVA. EFG International AG purchased a new stake in shares of Corteva in the second quarter valued at about $25,000. Compass Financial Management LLC purchased a new position in shares of Corteva during the second quarter worth about $25,000. JPL Wealth Management LLC acquired a new position in Corteva in the 3rd quarter valued at about $25,000. Garton & Associates Financial Advisors LLC purchased a new stake in Corteva during the 4th quarter valued at approximately $27,000. Finally, Bank of Jackson Hole Trust acquired a new stake in Corteva during the 4th quarter worth approximately $28,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Up 0.4%

Shares of NYSE CTVA opened at $83.18 on Wednesday. The stock has a fifty day moving average price of $82.39 and a 200 day moving average price of $80.37. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $90.97. The company has a market cap of $55.50 billion, a P/E ratio of 55.09, a P/E/G ratio of 2.54 and a beta of 0.57.

Corteva (NYSE:CTVA) last posted its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same period in the previous year, the company posted $2.20 earnings per share. The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Analysts Set New Price Targets

A number of research firms recently weighed in on CTVA. Weiss Ratings lowered shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Rothschild & Co Redburn boosted their target price on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. Royal Bank Of Canada increased their price target on Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 21st. Finally, Oppenheimer boosted their target price on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, July 23rd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $91.50.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.